BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2968947)

  • 41. The here and now of hepatitis B immunization.
    Grady GF
    N Engl J Med; 1986 Jul; 315(4):250-2. PubMed ID: 2941688
    [No Abstract]   [Full Text] [Related]  

  • 42. Immunisation against hepatitis B among NHS staff in West Midlands Regional Health Authority.
    Baddick MR; Aw TC
    BMJ; 1989 Sep; 299(6699):607. PubMed ID: 2529937
    [No Abstract]   [Full Text] [Related]  

  • 43. Hepatitis B immunisation: problems and practicalities in a primary school.
    Carter R; Miller J
    N Z Nurs J; 1991 Aug; 84(7):19. PubMed ID: 1831551
    [No Abstract]   [Full Text] [Related]  

  • 44. Role for monoclonal hepatitis B antibody in hepatitis B immunisation programmes.
    Celis E; Chang TW; Stricker L; Tiebout RF; Zeijlemaker WP
    Lancet; 1985 May; 1(8439):1219. PubMed ID: 2860421
    [No Abstract]   [Full Text] [Related]  

  • 45. Hepatitis B vaccines.
    N Z Med J; 1988 Dec; 101(859):831. PubMed ID: 2974517
    [No Abstract]   [Full Text] [Related]  

  • 46. [Hepatitis B virus infection in women treated with in-vitro fertilization].
    Alberda AT; van Os HC; Zeilmaker GH; Rothbarth PH; Heijtink RA; Schalm SW
    Ned Tijdschr Geneeskd; 1989 Jan; 133(1):20-5. PubMed ID: 2521690
    [No Abstract]   [Full Text] [Related]  

  • 47. Control of hepatitis B virus infection in Third-World countries.
    Prince AM
    Transfus Med Rev; 1990 Jul; 4(3):187-90. PubMed ID: 1966884
    [No Abstract]   [Full Text] [Related]  

  • 48. Immunization against hepatitis B.
    Savage CM
    Aust Dent J; 1985 Feb; 30(1):57. PubMed ID: 3161494
    [No Abstract]   [Full Text] [Related]  

  • 49. Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program.
    McMahon BJ; Bulkow LR; Singleton RJ; Williams J; Snowball M; Homan C; Parkinson AJ
    Hepatology; 2011 Sep; 54(3):801-7. PubMed ID: 21618565
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Hepatitis-B vaccination: unresolved questions].
    Jilg W
    Schweiz Rundsch Med Prax; 1992 Jun; 81(24):795-7. PubMed ID: 1534922
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Time for action on hepatitis B immunisation.
    Gatley MS
    Br Med J (Clin Res Ed); 1987 Feb; 294(6570):509. PubMed ID: 2950945
    [No Abstract]   [Full Text] [Related]  

  • 52. Elimination of new chronic hepatitis B virus infections: results of the Alaska immunization program.
    Harpaz R; McMahon BJ; Margolis HS; Shapiro CN; Havron D; Carpenter G; Bulkow LR; Wainwright RB
    J Infect Dis; 2000 Feb; 181(2):413-8. PubMed ID: 10669320
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Hepatitis A and B vaccines].
    Van Cauter J; Pestiaux A; Lenaerts A; Khrouz H
    Rev Med Brux; 1997 Sep; 18(4):187-91. PubMed ID: 9411640
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatitis B epidemiology and prevention.
    Shapiro CN; Margolis HS
    Epidemiol Rev; 1990; 12():221-7. PubMed ID: 2149555
    [No Abstract]   [Full Text] [Related]  

  • 55. Time for action on hepatitis B immunisation.
    Polakoff S
    Br Med J (Clin Res Ed); 1987 Apr; 294(6578):1031. PubMed ID: 2960417
    [No Abstract]   [Full Text] [Related]  

  • 56. Current status of active immunization against hepatitis B infections.
    Gust ID
    Malays J Pathol; 1985 Aug; 7():1-6. PubMed ID: 2952843
    [No Abstract]   [Full Text] [Related]  

  • 57. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Global control of hepatitis B through vaccination: role of hepatitis B vaccine in the Expanded Programme on Immunization.
    Maynard JE; Kane MA; Hadler SC
    Rev Infect Dis; 1989; 11 Suppl 3():S574-8. PubMed ID: 2527402
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunogenicity of a combined hepatitis B and Haemophilus influenzae type b conjugate vaccine in Alaska Native infants.
    Petersen K; Bulkow L; McMahon B; Wainwright R; Peters H
    Int J Circumpolar Health; 1998; 57 Suppl 1():285-92. PubMed ID: 10093291
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Should individuals with anti-HBs as the only marker of infection with hepatitis B receive hepatitis B vaccine?
    MacLeod JE; MacSween HM; Warner HA; Aterman K
    Can J Public Health; 1985; 76(4):229-32. PubMed ID: 2932209
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.